Sales

583.1

242.1

1,191.5

470.3

373.5

398.3

781.4

749.7

Royalty, license and commission income

0.6

2.3

3.5

3.7

–

1.0

0.8

4.5

Total revenues

583.7

244.4

1,195.0

474.0

373.5

399.2

782.2

754.1

Gross margin

329.8

127.6

686.0

254.5

198.7

266.0

462.9

491.9

Marketing and selling expenses

–147.2

–63.8

–293.3

–121.5

–33.8

–33.9

–66.4

–64.4

Royalty, license and commission expenses

–3.9

–1.3

–7.0

–3.1

–1.3

–2.4

–2.9

–5.9

Administration expenses

–25.5

–11.6

–53.7

–22.0

–9.0

–10.7

–17.7

–20.0

Other operating expenses and income

–29.7

–46.0

–56.8

–60.8

–10.9

–20.0

–26.0

–38.3

Research and development

–31.9

–6.5

–64.5

–13.3

–30.1

–30.0

–66.5

–61.3

Operating result

46.3

–1.4

118.2

33.8

104.3

167.5

273.1

299.0

Exceptional items

–

–

–

–

0.4

–

157.4

–

Earnings before interest and tax (EBIT)

46.3

–1.4

118.2

33.8

104.7

167.5

430.6

299.0

Net operating assets**

–

–

6,134.4

6,435.7

–

–

1,258.3

1,289.8

Segment liabilities**

–

–

–304.1

–361.4

–

–

–144.4

–166.8

Capital spending on property, plant and equipment

26.3

12.2

42.3

20.1

12.5

16.0

25.8

25.2

Investments in intangible assets

1.7

1.4

2.7

2.1

0.5

0.9

1.3

1.5

Depreciation and amortization

–68.7

–11.5

–140.7

–23.2

–24.9

–23.6

–51.9

–47.0

Impairment losses

–2.0

–

–2.0

–

–9.4

–7.4

–9.4

–16.4

Net cash flows from operating activities

90.6

35.7

156.1

65.7

167.1

168.4

284.0

283.9

Net cash flows from investing activities

–31.5

–14.5

–45.6

–24.9

–13.1

–15.5

168.5

–24.4

Free cash flow

59.1

21.2

110.5

40.7

153.9

152.9

452.5

259.6

Underlying free cash flow

69.1

21.2

126.9

40.7

154.0

152.9

251.6

259.6

FCR in %

11.8

8.7

10.6

8.6

41.2

38.3

32.2

34.4

ROS in %

7.9

–0.6

9.9

7.1

27.9

41.9

34.9

39.6

Chemicals

€ million

Q2
2011

Q2
2010

Jan.–June
2011

Jan.–June
2010

Sales

956.5

640.3

1,972.9

1,220.0

Royalty, license and commission income

0.7

3.3

4.3

8.2

Total revenues

957.2

643.6

1,977.1

1,228.1

Gross margin

528.4

393.5

1,148.9

746.4

Marketing and selling expenses

–181.0

–97.8

–359.8

–185.9

Royalty, license and commission expenses

–5.3

–3.7

–9.9

–8.9

Administration expenses

–34.5

–22.3

–71.4

–42.0

Other operating expenses and income

–40.6

–66.1

–82.8

–99.1

Research and development

–62.0

–36.5

–131.0

–74.5

Operating result

150.6

166.0

391.4

332.8

Exceptional items

0.4

–

157.4

–

Earnings before interest and tax (EBIT)

151.0

166.0

548.8

332.8

Net operating assets**

–

–

7,392.7

7,725.3

Segment liabilities**

–

–

–448.5

–528.2

Capital spending on property, plant and equipment

38.8

28.2

68.1

45.3

Investments in intangible assets

2.3

2.3

4.0

3.6

Depreciation and amortization

–93.6

–35.1

–192.5

–70.2

Impairment losses

–11.4

–7.4

–11.4

–16.4

Net cash flows from operating activities

257.6

204.0

440.1

349.6

Net cash flows from investing activities

–44.7

–30.0

122.9

–49.3

Free cash flow

213.0

174.0

563.0

300.3

Underlying free cash flow

223.1

174.0

378.5

300.3

FCR in %

23.3

27.0

19.1

24.5

ROS in %

15.7

25.8

19.8

27.1